Who owns par pharmaceuticals? In 2015, Endo acquired the specialty generics and sterile injectables company Par Pharmaceutical for $8.05 billion. In 2018, Endo settled over 1,200 lawsuits related to its testosterone replacement therapy, Testim, and its undisclosed side effects.What is para pharmaceutical? Par is a pharmaceutical company that develops, manufacturers and markets safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life.What is the pharmacy phone number? To best serve you, our representatives specialize in the following business areas. Here’s how to contact them. For questions and comments including feedback about our stores, pharmacy, policies and in-store photo department, call 1-800-SHOP-CVS (1-800-746-7287) Monday-Friday 8 AM - 10 PM ET, Sat. & Sun.
Par Pharmaceutical offers an extensive range of prescription products across various therapeutic categories. Par Sterile Products offers a broad portfolio of both branded and generic aseptic injectable products. Our impressive portfolio of prescription products is comprised of liquid, solids and semi-solids, among other dosage forms.